| Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C19 and voriconazole therapy B Moriyama, AO Obeng, J Barbarino, SR Penzak, SA Henning, SA Scott, ... Clinical Pharmacology & Therapeutics 102 (1), 45-51, 2017 | 341 | 2017 |
| Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1 E Mamcarz, S Zhou, T Lockey, H Abdelsamed, SJ Cross, G Kang, Z Ma, ... New England Journal of Medicine 380 (16), 1525-1534, 2019 | 256 | 2019 |
| Development and use of active clinical decision support for preemptive pharmacogenomics GC Bell, KR Crews, MR Wilkinson, CE Haidar, JK Hicks, DK Baker, ... Journal of the American Medical Informatics Association 21 (e1), e93-e99, 2014 | 229 | 2014 |
| Multicenter initial guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2 K Chiotos, M Hayes, DW Kimberlin, SB Jones, SH James, SG Pinninti, ... Journal of the Pediatric Infectious Diseases Society 9 (6), 701-715, 2020 | 181 | 2020 |
| Development and implementation of a pharmacist-managed clinical pharmacogenetics service KR Crews, SJ Cross, JN McCormick, DK Baker, AR Molinelli, R Mullins, ... American Journal of Health-System Pharmacy 68 (2), 143-150, 2011 | 169 | 2011 |
| Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2 K Chiotos, M Hayes, DW Kimberlin, SB Jones, SH James, SG Pinninti, ... Journal of the Pediatric Infectious Diseases Society 10 (1), 34-48, 2021 | 139 | 2021 |
| A clinician‐driven automated system for integration of pharmacogenetic interpretations into an electronic medical record JK Hicks, KR Crews, JM Hoffman, NM Kornegay, MR Wilkinson, R Lorier, ... Clinical Pharmacology & Therapeutics 92 (5), 563-566, 2012 | 112 | 2012 |
| Posaconazole therapeutic drug monitoring in pediatric patients and young adults with cancer VA Bernardo, SJ Cross, KR Crews, PM Flynn, JM Hoffman, KM Knapp, ... Annals of Pharmacotherapy 47 (7-8), 976-983, 2013 | 66 | 2013 |
| Selective T‐cell depletion targeting CD 45 RA reduces viremia and enhances early T‐cell recovery compared with CD 3‐targeted T‐cell depletion BM Triplett, B Muller, G Kang, Y Li, SJ Cross, J Moen, L Cunningham, ... Transplant Infectious Disease 20 (1), e12823, 2018 | 52 | 2018 |
| Phase I study of the tolerability and pharmacokinetics of palifermin in children undergoing allogeneic hematopoietic stem cell transplantation A Srinivasan, KA Kasow, S Cross, M Parrish, C Wang, DK Srivastava, ... Biology of Blood and Marrow Transplantation 18 (8), 1309-1314, 2012 | 29 | 2012 |
| Derivation of new equations to estimate glomerular filtration rate in pediatric oncology patients VE Millisor, JK Roberts, Y Sun, L Tang, VM Daryani, D Gregornik, ... Pediatric Nephrology 32, 1575-1584, 2017 | 24 | 2017 |
| Abacavir and metabolite pharmacokinetics in HIV-1–Infected children and adolescents SJ Cross, JH Rodman, JC Lindsey, BL Robbins, CH Rose, GJ Yuen, ... Journal of acquired immune deficiency syndromes (1999) 51 (1), 54, 2009 | 16 | 2009 |
| Rotavirus Infection in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients T Flerlage, R Hayden, SJ Cross, R Dallas, A Srinivasan, L Tang, Y Sun, ... The Pediatric infectious disease journal 37 (2), 176-181, 2018 | 13 | 2018 |
| Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory … A Srinivasan, JC Panetta, SJ Cross, A Pillai, BM Triplett, DR Shook, ... Biology of Blood and Marrow Transplantation 20 (8), 1224-1228, 2014 | 10 | 2014 |
| Pharmacokinetics of alemtuzumab in pediatric patients undergoing ex vivo T-cell-depleted haploidentical hematopoietic cell transplantation SV Bhoopalan, SJ Cross, JC Panetta, BM Triplett Cancer chemotherapy and pharmacology 86, 711-717, 2020 | 9 | 2020 |
| Aprepitant reduces chemotherapy-induced vomiting in children and young adults with brain tumors K Duggin, K Tickle, G Norman, J Yang, C Wang, SJ Cross, A Gajjar, ... Journal of Pediatric Oncology Nursing 31 (5), 277-283, 2014 | 9 | 2014 |
| Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia SE Karol, Y Sun, L Tang, CH Pui, J Ferrolino, KJ Allison, SJ Cross, ... Cancer medicine 9 (18), 6550-6555, 2020 | 8 | 2020 |
| Managing local‐regional failure in children with high‐risk neuroblastoma: A single institution experience AP Dove, BA Manole, DV Wakefield, SJ Cross, M Doubrovin, BL Shulkin, ... Pediatric blood & cancer 65 (12), e27408, 2018 | 8 | 2018 |
| Abacavir Pharmacokinetics During Chronic Therapy in HIV‐1‐Infected Adolescents and Young Adults JW Sleasman, BL Robbins, SJ Cross, JC Lindsey, JM Kraimer, ... Clinical Pharmacology & Therapeutics 85 (4), 394-401, 2009 | 8 | 2009 |
| Human astrovirus VA1 encephalitis in pediatric patients with cancer: report of 2 cases and review of the literature S Bami, J Hidinger, A Madni, V Hargest, S Schultz-Cherry, V Cortez, ... Journal of the Pediatric Infectious Diseases Society 11 (9), 408-412, 2022 | 6 | 2022 |
